Annual D&A
$144.90 M
+$5.30 M+3.80%
31 December 2023
Summary:
Edwards Lifesciences annual depreciation & amortization is currently $144.90 million, with the most recent change of +$5.30 million (+3.80%) on 31 December 2023. During the last 3 years, it has risen by +$37.70 million (+35.17%). EW annual D&A is now at all-time high.EW Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$34.50 M
-$5.10 M-12.88%
30 September 2024
Summary:
Edwards Lifesciences quarterly depreciation & amortization is currently $34.50 million, with the most recent change of -$5.10 million (-12.88%) on 30 September 2024. Over the past year, it has dropped by -$2.40 million (-6.50%). EW quarterly D&A is now -12.88% below its all-time high of $39.60 million, reached on 30 June 2024.EW Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$149.30 M
-$2.40 M-1.58%
30 September 2024
Summary:
Edwards Lifesciences TTM depreciation & amortization is currently $149.30 million, with the most recent change of -$2.40 million (-1.58%) on 30 September 2024. Over the past year, it has increased by +$5.70 million (+3.97%). EW TTM D&A is now -1.58% below its all-time high of $151.70 million, reached on 30 June 2024.EW TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EW Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.8% | -6.5% | +4.0% |
| 3 y3 years | +35.2% | +2.7% | +11.1% |
| 5 y5 years | +87.2% | +49.4% | +75.0% |
EW Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +35.2% | -12.9% | +4.5% | -1.6% | +11.1% |
| 5 y | 5 years | at high | +87.2% | -12.9% | +49.4% | -1.6% | +75.0% |
| alltime | all time | at high | +258.7% | -12.9% | +259.4% | -1.6% | +611.0% |
Edwards Lifesciences Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $34.50 M(-12.9%) | $149.30 M(-1.6%) |
| June 2024 | - | $39.60 M(+2.9%) | $151.70 M(+2.4%) |
| Mar 2024 | - | $38.50 M(+4.9%) | $148.20 M(+2.3%) |
| Dec 2023 | $144.90 M(+3.8%) | $36.70 M(-0.5%) | $144.90 M(+0.9%) |
| Sept 2023 | - | $36.90 M(+2.2%) | $143.60 M(+1.1%) |
| June 2023 | - | $36.10 M(+2.6%) | $142.10 M(+1.4%) |
| Mar 2023 | - | $35.20 M(-0.6%) | $140.10 M(+0.4%) |
| Dec 2022 | $139.60 M(+3.6%) | $35.40 M(0.0%) | $139.60 M(+1.7%) |
| Sept 2022 | - | $35.40 M(+3.8%) | $137.20 M(+1.3%) |
| June 2022 | - | $34.10 M(-1.7%) | $135.40 M(-1.2%) |
| Mar 2022 | - | $34.70 M(+5.2%) | $137.10 M(+1.7%) |
| Dec 2021 | $134.80 M(+25.7%) | $33.00 M(-1.8%) | $134.80 M(+0.3%) |
| Sept 2021 | - | $33.60 M(-6.1%) | $134.40 M(+6.3%) |
| June 2021 | - | $35.80 M(+10.5%) | $126.40 M(+9.8%) |
| Mar 2021 | - | $32.40 M(-0.6%) | $115.10 M(+7.4%) |
| Dec 2020 | $107.20 M(+20.0%) | $32.60 M(+27.3%) | $107.20 M(+8.8%) |
| Sept 2020 | - | $25.60 M(+4.5%) | $98.50 M(+2.6%) |
| June 2020 | - | $24.50 M(0.0%) | $96.00 M(+3.0%) |
| Mar 2020 | - | $24.50 M(+2.5%) | $93.20 M(+4.4%) |
| Dec 2019 | $89.30 M(+15.4%) | $23.90 M(+3.5%) | $89.30 M(+4.7%) |
| Sept 2019 | - | $23.10 M(+6.5%) | $85.30 M(+4.8%) |
| June 2019 | - | $21.70 M(+5.3%) | $81.40 M(+3.2%) |
| Mar 2019 | - | $20.60 M(+3.5%) | $78.90 M(+1.9%) |
| Dec 2018 | $77.40 M(-5.5%) | $19.90 M(+3.6%) | $77.40 M(-1.7%) |
| Sept 2018 | - | $19.20 M(0.0%) | $78.70 M(-1.9%) |
| June 2018 | - | $19.20 M(+0.5%) | $80.20 M(+0.4%) |
| Mar 2018 | - | $19.10 M(-9.9%) | $79.90 M(-2.4%) |
| Dec 2017 | $81.90 M(+15.0%) | $21.20 M(+2.4%) | $81.90 M(+2.6%) |
| Sept 2017 | - | $20.70 M(+9.5%) | $79.80 M(+3.2%) |
| June 2017 | - | $18.90 M(-10.4%) | $77.30 M(+1.2%) |
| Mar 2017 | - | $21.10 M(+10.5%) | $76.40 M(+7.3%) |
| Dec 2016 | $71.20 M(+8.2%) | $19.10 M(+4.9%) | $71.20 M(+6.9%) |
| Sept 2016 | - | $18.20 M(+1.1%) | $66.60 M(-0.4%) |
| June 2016 | - | $18.00 M(+13.2%) | $66.90 M(+1.8%) |
| Mar 2016 | - | $15.90 M(+9.7%) | $65.70 M(-0.2%) |
| Dec 2015 | $65.80 M(-4.1%) | $14.50 M(-21.6%) | $65.80 M(-5.5%) |
| Sept 2015 | - | $18.50 M(+10.1%) | $69.60 M(+0.7%) |
| June 2015 | - | $16.80 M(+5.0%) | $69.10 M(+1.0%) |
| Mar 2015 | - | $16.00 M(-12.6%) | $68.40 M(-0.3%) |
| Dec 2014 | $68.60 M(+9.1%) | $18.30 M(+1.7%) | $68.60 M(+1.8%) |
| Sept 2014 | - | $18.00 M(+11.8%) | $67.40 M(+1.5%) |
| June 2014 | - | $16.10 M(-0.6%) | $66.40 M(+2.2%) |
| Mar 2014 | - | $16.20 M(-5.3%) | $65.00 M(+3.3%) |
| Dec 2013 | $62.90 M(+17.1%) | $17.10 M(+0.6%) | $62.90 M(+9.8%) |
| Sept 2013 | - | $17.00 M(+15.6%) | $57.30 M(+4.8%) |
| June 2013 | - | $14.70 M(+4.3%) | $54.70 M(+1.3%) |
| Mar 2013 | - | $14.10 M(+22.6%) | $54.00 M(+0.6%) |
| Dec 2012 | $53.70 M | $11.50 M(-20.1%) | $53.70 M(-5.8%) |
| Sept 2012 | - | $14.40 M(+2.9%) | $57.00 M(+0.9%) |
| June 2012 | - | $14.00 M(+1.4%) | $56.50 M(-1.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $13.80 M(-6.8%) | $57.30 M(-1.2%) |
| Dec 2011 | $58.00 M(+2.7%) | $14.80 M(+6.5%) | $58.00 M(-1.0%) |
| Sept 2011 | - | $13.90 M(-6.1%) | $58.60 M(+0.9%) |
| June 2011 | - | $14.80 M(+2.1%) | $58.10 M(+1.9%) |
| Mar 2011 | - | $14.50 M(-5.8%) | $57.00 M(+0.9%) |
| Dec 2010 | $56.50 M(-3.7%) | $15.40 M(+14.9%) | $56.50 M(+2.2%) |
| Sept 2010 | - | $13.40 M(-2.2%) | $55.30 M(-3.5%) |
| June 2010 | - | $13.70 M(-2.1%) | $57.30 M(-2.1%) |
| Mar 2010 | - | $14.00 M(-1.4%) | $58.50 M(-0.3%) |
| Dec 2009 | $58.70 M(+5.6%) | $14.20 M(-7.8%) | $58.70 M(-0.2%) |
| Sept 2009 | - | $15.40 M(+3.4%) | $58.80 M(+2.8%) |
| June 2009 | - | $14.90 M(+4.9%) | $57.20 M(+1.6%) |
| Mar 2009 | - | $14.20 M(-0.7%) | $56.30 M(+1.3%) |
| Dec 2008 | $55.60 M(+1.5%) | $14.30 M(+3.6%) | $55.60 M(+1.1%) |
| Sept 2008 | - | $13.80 M(-1.4%) | $55.00 M(-0.4%) |
| June 2008 | - | $14.00 M(+3.7%) | $55.20 M(+0.5%) |
| Mar 2008 | - | $13.50 M(-1.5%) | $54.90 M(+0.2%) |
| Dec 2007 | $54.80 M(-3.5%) | $13.70 M(-2.1%) | $54.80 M(-1.6%) |
| Sept 2007 | - | $14.00 M(+2.2%) | $55.70 M(+0.4%) |
| June 2007 | - | $13.70 M(+2.2%) | $55.50 M(-0.9%) |
| Mar 2007 | - | $13.40 M(-8.2%) | $56.00 M(-1.4%) |
| Dec 2006 | $56.80 M(+1.1%) | $14.60 M(+5.8%) | $56.80 M(+0.4%) |
| Sept 2006 | - | $13.80 M(-2.8%) | $56.60 M(-0.4%) |
| June 2006 | - | $14.20 M(0.0%) | $56.80 M(0.0%) |
| Mar 2006 | - | $14.20 M(-1.4%) | $56.80 M(+1.1%) |
| Dec 2005 | $56.20 M(+0.9%) | $14.40 M(+2.9%) | $56.20 M(-0.4%) |
| Sept 2005 | - | $14.00 M(-1.4%) | $56.40 M(-2.3%) |
| June 2005 | - | $14.20 M(+4.4%) | $57.70 M(+1.9%) |
| Mar 2005 | - | $13.60 M(-6.8%) | $56.60 M(+1.6%) |
| Dec 2004 | $55.70 M(+22.1%) | $14.60 M(-4.6%) | $55.70 M(+5.7%) |
| Sept 2004 | - | $15.30 M(+16.8%) | $52.70 M(+6.9%) |
| June 2004 | - | $13.10 M(+3.1%) | $49.30 M(+3.8%) |
| Mar 2004 | - | $12.70 M(+9.5%) | $47.50 M(+4.2%) |
| Dec 2003 | $45.60 M(+12.9%) | $11.60 M(-2.5%) | $45.60 M(+1.3%) |
| Sept 2003 | - | $11.90 M(+5.3%) | $45.00 M(+4.2%) |
| June 2003 | - | $11.30 M(+4.6%) | $43.20 M(+4.1%) |
| Mar 2003 | - | $10.80 M(-1.8%) | $41.50 M(+2.7%) |
| Dec 2002 | $40.40 M(-29.1%) | $11.00 M(+8.9%) | $40.40 M(-3.8%) |
| Sept 2002 | - | $10.10 M(+5.2%) | $42.00 M(-2.3%) |
| June 2002 | - | $9.60 M(-1.0%) | $43.00 M(-14.7%) |
| Mar 2002 | - | $9.70 M(-23.0%) | $50.40 M(-11.6%) |
| Dec 2001 | $57.00 M(-23.0%) | $12.60 M(+13.5%) | $57.00 M(-3.4%) |
| Sept 2001 | - | $11.10 M(-34.7%) | $59.00 M(-6.8%) |
| June 2001 | - | $17.00 M(+4.3%) | $63.30 M(-8.7%) |
| Mar 2001 | - | $16.30 M(+11.6%) | $69.30 M(-6.4%) |
| Dec 2000 | $74.00 M(-11.9%) | $14.60 M(-5.2%) | $74.00 M(+24.6%) |
| Sept 2000 | - | $15.40 M(-33.0%) | $59.40 M(+35.0%) |
| June 2000 | - | $23.00 M(+9.5%) | $44.00 M(+109.5%) |
| Mar 2000 | - | $21.00 M | $21.00 M |
| Dec 1999 | $84.00 M | - | - |
FAQ
- What is Edwards Lifesciences annual depreciation & amortization?
- What is the all time high annual D&A for Edwards Lifesciences?
- What is Edwards Lifesciences annual D&A year-on-year change?
- What is Edwards Lifesciences quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Edwards Lifesciences?
- What is Edwards Lifesciences quarterly D&A year-on-year change?
- What is Edwards Lifesciences TTM depreciation & amortization?
- What is the all time high TTM D&A for Edwards Lifesciences?
- What is Edwards Lifesciences TTM D&A year-on-year change?
What is Edwards Lifesciences annual depreciation & amortization?
The current annual D&A of EW is $144.90 M
What is the all time high annual D&A for Edwards Lifesciences?
Edwards Lifesciences all-time high annual depreciation & amortization is $144.90 M
What is Edwards Lifesciences annual D&A year-on-year change?
Over the past year, EW annual depreciation & amortization has changed by +$5.30 M (+3.80%)
What is Edwards Lifesciences quarterly depreciation & amortization?
The current quarterly D&A of EW is $34.50 M
What is the all time high quarterly D&A for Edwards Lifesciences?
Edwards Lifesciences all-time high quarterly depreciation & amortization is $39.60 M
What is Edwards Lifesciences quarterly D&A year-on-year change?
Over the past year, EW quarterly depreciation & amortization has changed by -$2.40 M (-6.50%)
What is Edwards Lifesciences TTM depreciation & amortization?
The current TTM D&A of EW is $149.30 M
What is the all time high TTM D&A for Edwards Lifesciences?
Edwards Lifesciences all-time high TTM depreciation & amortization is $151.70 M
What is Edwards Lifesciences TTM D&A year-on-year change?
Over the past year, EW TTM depreciation & amortization has changed by +$5.70 M (+3.97%)